Literature DB >> 24764780

Discontinuation of nucleoside analogues in hepatitis B virus infection.

Pietro Lampertico1.   

Abstract

Entities:  

Year:  2013        PMID： 24764780      PMCID： PMC3992060     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.

Authors:  Jurriën G P Reijnders; Moniek J Perquin; Ningping Zhang; Bettina E Hansen; Harry L A Janssen
Journal:  Gastroenterology       Date:  2010-04-08       Impact factor: 22.682

2.  Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a.

Authors:  Vincent Rijckborst; Bettina E Hansen; Peter Ferenci; Maurizia R Brunetto; Fehmi Tabak; Yilmaz Cakaloglu; A Galeota Lanza; Vincenzo Messina; Claudio Iannacone; Benedetta Massetto; Loredana Regep; Massimo Colombo; Harry L A Janssen; Pietro Lampertico
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

3.  HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years.

Authors:  Massimo Fasano; Pietro Lampertico; Alfredo Marzano; Vito Di Marco; Grazia Anna Niro; Giuseppina Brancaccio; Andrea Marengo; Gaetano Scotto; Maurizia Rossana Brunetto; Giovanni Battista Gaeta; Mario Rizzetto; Gioacchino Angarano; Teresa Santantonio
Journal:  J Hepatol       Date:  2012-02-16       Impact factor: 25.083

4.  Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients.

Authors:  Masataka Tsuge; Eisuke Murakami; Michio Imamura; Hiromi Abe; Daiki Miki; Nobuhiko Hiraga; Shoichi Takahashi; Hidenori Ochi; C Nelson Hayes; Hiroyuki Ginba; Kazuhiro Matsuyama; Hiroiku Kawakami; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2013-02-09       Impact factor: 7.527
  4 in total
  1 in total

1.  Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Kyle E Korolowicz; Manasa Suresh; Bin Li; Xu Huang; Changsuek Yon; Xuebing Leng; Bhaskar V Kallakury; Robin D Tucker; Stephan Menne
Journal:  Viruses       Date:  2021-04-09       Impact factor: 5.048
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.